State Street Corporation has appointed healthcare product producer Covidien chairman José (Joe) E. Almeida to its board of directors.
With more than 18 years leadership experience at the large public company, Almeida will bring a valuable knowledge of innovation and competition to the financial services research group, Joseph L. Hooley, chairman, president and chief executive officer of State Street Corporation, said.
Almeida joined Covidien in 1995 and has served as chairman of the company's board of directors since March 2012.
He has also previously held senior roles at Greatbatch Technologies, Inc., American Home Products' Acufex Microsurgical division and Johnson & Johnson's professional products division.
Almeida is also on the board of directors at Advanced Medical Technology Association (AdvaMed) and Partners in Health.
The fund has hired a former ART executive as its new head of group strategy.
The sovereign wealth fund has revealed six internal hires to support the execution of key strategies.
The fund has announced the departure of a second senior executive in as many months, with its chief member officer to finish up mid-December.
The $89 billion fund has announced a new leadership role within its private markets team.